Evidence map›Paper›PMID 36365187›Full record

ArticlePharmaceutics2022

The Ethanolic Extract of

Fabricia Rodrigues Salustriano, Antonio Carlos Duenhas Monreal, Silvia Cordeiro das Neves, Giovana Martins de Oliveira, Diego Duarte Marques de Oliveira, Marcelo Luiz Brandão Vilela, Valter Aragão do Nascimento, Allana Cristina Faustino Martins, Baby Saroja, Arunachalam Karuppusamy and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. The Ethanolic Extract ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Fabricia Rodrigues SalustrianoCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.
Antonio Carlos Duenhas MonrealCampus II de Três Lagoas, Universidade Federal de Mato Grosso do Sul, Três Lagoas 79602-070, MS, Brazil.
Silvia Cordeiro das NevesCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.
Giovana Martins de OliveiraCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.
Diego Duarte Marques de OliveiraCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.ORCID 0000-0003-0363-8942
Marcelo Luiz Brandão VilelaFaculdade de Medicina Dr. Hélio Mandetta (FAMED), Universidade Federal de Mato Grosso do Sul (UFMS), Campo Grande 79070-900, MS, Brazil.
Valter Aragão do NascimentoCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.
Allana Cristina Faustino MartinsDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58102, USA.ORCID 0000-0001-5647-2187
Baby SarojaDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58102, USA.
Arunachalam KaruppusamyCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.ORCID 0000-0001-9146-7068
Henrique Rodrigues Scherer CoelhoCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.ORCID 0000-0003-2438-6510
Candida Aparecida Leite KassuyaFaculdade de Ciências da Saúde, Universidade Federal da Grande Dourados (UFGD), Dourados 79804-970, MS, Brazil.ORCID 0000-0002-8998-9219
Dayanna Isabel Araque GelvesInstituto de Biologia, Departamento de Biologia Vegetal, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-862, SP, Brazil.
Marcos José SalvadorInstituto de Biologia, Departamento de Biologia Vegetal, Universidade Estadual de Campinas (UNICAMP), Campinas 13083-862, SP, Brazil.ORCID 0000-0002-3839-5445
Rodrigo Juliano OliveiraCentro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica (CeTroGen), Campo Grande 79070-900, MS, Brazil.
Roberto da Silva GomesDepartment of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58102, USA.ORCID 0000-0002-8075-9716
Universidade Federal de Mato Grosso do Sul · BRNorth Dakota State University · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Federal da Grande Dourados · BR

Funding

Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancerP20GM109024 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI Sanku Mallik · 2016 to 2026
$20.5M
National Institute of Health 1P20GM109024National Science Foundation FAR0021960, FAR0034259 and FAR0035377NIGMS NIH HHS P20 GM109024São Paulo Research Foundation 21/09693-5; 15/03726-8 and 06/06079-4
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chromosomal damageGomphrena celosioidesteratogenesistoxicity

Identifiers

PMID36365187
PMCPMC9695157
OpenAlexW4308415773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.